Answers are grounded in this paper and cite their sources.
In this preliminary study of children with ALL, an inherited polymorphism in the promoter region of CEP72 was associated with increased risk and severity of vincristine-related peripheral neuropathy. If replicated in additional populations, this finding may provide a basis for safer dosing of this widely prescribed anticancer agent.
No takes yet. Share an insight, caveat, or question.
Berg et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: